Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 69

1.

Respiratory virus transmission dynamics determine timing of asthma exacerbation peaks: Evidence from a population-level model.

Eggo RM, Scott JG, Galvani AP, Meyers LA.

Proc Natl Acad Sci U S A. 2016 Feb 8. pii: 201518677. [Epub ahead of print]

PMID:
26858436
2.

Evaluating Ebola vaccine trials: insights from simulation.

Pulliam JR, Bellan SE, Gambhir M, Meyers LA, Dushoff J.

Lancet Infect Dis. 2015 Oct;15(10):1134. doi: 10.1016/S1473-3099(15)00303-5. Epub 2015 Sep 20. No abstract available.

PMID:
26461945
3.

Epidemic Wave Dynamics Attributable to Urban Community Structure: A Theoretical Characterization of Disease Transmission in a Large Network.

Hoen AG, Hladish TJ, Eggo RM, Lenczner M, Brownstein JS, Meyers LA.

J Med Internet Res. 2015 Jul 8;17(7):e169. doi: 10.2196/jmir.3720.

4.

Correction: Harnessing Case Isolation and Ring Vaccination to Control Ebola.

Wells C, Yamin D, Ndeffo-Mbah ML, Wenzel N, Gaffney SG, Townsend JP, Meyers LA, Fallah M, Nyenswah TG, Altice FL, Atkins KE, Galvani AP.

PLoS Negl Trop Dis. 2015 Jun 24;9(6):e0003888. doi: 10.1371/journal.pntd.0003888. eCollection 2015 Jun. No abstract available.

5.

Harnessing case isolation and ring vaccination to control Ebola.

Wells C, Yamin D, Ndeffo-Mbah ML, Wenzel N, Gaffney SG, Townsend JP, Meyers LA, Fallah M, Nyenswah TG, Altice FL, Atkins KE, Galvani AP.

PLoS Negl Trop Dis. 2015 May 29;9(5):e0003794. doi: 10.1371/journal.pntd.0003794. eCollection 2015 May. Erratum in: PLoS Negl Trop Dis. 2015 Jun;9(6):e0003888.

6.

Statistical power and validity of Ebola vaccine trials in Sierra Leone: a simulation study of trial design and analysis.

Bellan SE, Pulliam JR, Pearson CA, Champredon D, Fox SJ, Skrip L, Galvani AP, Gambhir M, Lopman BA, Porco TC, Meyers LA, Dushoff J.

Lancet Infect Dis. 2015 Jun;15(6):703-10. doi: 10.1016/S1473-3099(15)70139-8. Epub 2015 Apr 14.

PMID:
25886798
7.

Reassessment of HIV-1 acute phase infectivity: accounting for heterogeneity and study design with simulated cohorts.

Bellan SE, Dushoff J, Galvani AP, Meyers LA.

PLoS Med. 2015 Mar 17;12(3):e1001801. doi: 10.1371/journal.pmed.1001801. eCollection 2015 Mar.

8.

Efficacy and optimization of palivizumab injection regimens against respiratory syncytial virus infection.

Gutfraind A, Galvani AP, Meyers LA.

JAMA Pediatr. 2015 Apr;169(4):341-8. doi: 10.1001/jamapediatrics.2014.3804.

PMID:
25706618
9.

Evaluating large-scale blood transfusion therapy for the current Ebola epidemic in Liberia.

Gutfraind A, Meyers LA.

J Infect Dis. 2015 Apr 15;211(8):1262-7. doi: 10.1093/infdis/jiv042. Epub 2015 Jan 29.

PMID:
25635118
10.

Optimizing distribution of pandemic influenza antiviral drugs.

Singh B, Huang HC, Morton DP, Johnson GP, Gutfraind A, Galvani AP, Clements B, Meyers LA.

Emerg Infect Dis. 2015 Feb;21(2):251-8. doi: 10.3201/eid2102.141024.

11.

Epidemiological and viral genomic sequence analysis of the 2014 ebola outbreak reveals clustered transmission.

Scarpino SV, Iamarino A, Wells C, Yamin D, Ndeffo-Mbah M, Wenzel NS, Fox SJ, Nyenswah T, Altice FL, Galvani AP, Meyers LA, Townsend JP.

Clin Infect Dis. 2015 Apr 1;60(7):1079-82. doi: 10.1093/cid/ciu1131. Epub 2014 Dec 15.

PMID:
25516185
12.

Opinion: Mathematical models: a key tool for outbreak response.

Lofgren ET, Halloran ME, Rivers CM, Drake JM, Porco TC, Lewis B, Yang W, Vespignani A, Shaman J, Eisenberg JN, Eisenberg MC, Marathe M, Scarpino SV, Alexander KA, Meza R, Ferrari MJ, Hyman JM, Meyers LA, Eubank S.

Proc Natl Acad Sci U S A. 2014 Dec 23;111(51):18095-6. doi: 10.1073/pnas.1421551111. Epub 2014 Dec 10. No abstract available.

13.

Ebola virus vaccine trials: the ethical mandate for a therapeutic safety net.

Bellan SE, Pulliam JR, Dushoff J, Meyers LA.

BMJ. 2014 Dec 10;349:g7518. doi: 10.1136/bmj.g7518. No abstract available.

14.

Ebola control: effect of asymptomatic infection and acquired immunity.

Bellan SE, Pulliam JR, Dushoff J, Meyers LA.

Lancet. 2014 Oct 25;384(9953):1499-500. doi: 10.1016/S0140-6736(14)61839-0. Epub 2014 Oct 15. No abstract available.

PMID:
25390569
15.

Polyploid formation shapes flowering plant diversity.

Scarpino SV, Levin DA, Meyers LA.

Am Nat. 2014 Oct;184(4):456-65. doi: 10.1086/677752. Epub 2014 Aug 18.

PMID:
25226181
16.

Network-based vaccination improves prospects for disease control in wild chimpanzees.

Rushmore J, Caillaud D, Hall RJ, Stumpf RM, Meyers LA, Altizer S.

J R Soc Interface. 2014 Aug 6;11(97):20140349. doi: 10.1098/rsif.2014.0349.

17.

Probabilistic uncertainty analysis of epidemiological modeling to guide public health intervention policy.

Gilbert JA, Meyers LA, Galvani AP, Townsend JP.

Epidemics. 2014 Mar;6:37-45. doi: 10.1016/j.epidem.2013.11.002. Epub 2013 Nov 19.

18.

Cost-effectiveness of canine vaccination to prevent human rabies in rural Tanzania.

Fitzpatrick MC, Hampson K, Cleaveland S, Mzimbiri I, Lankester F, Lembo T, Meyers LA, Paltiel AD, Galvani AP.

Ann Intern Med. 2014 Jan 21;160(2):91-100.

19.

Potential cost-effectiveness of schistosomiasis treatment for reducing HIV transmission in Africa--the case of Zimbabwean women.

Ndeffo Mbah ML, Poolman EM, Atkins KE, Orenstein EW, Meyers LA, Townsend JP, Galvani AP.

PLoS Negl Trop Dis. 2013 Aug 1;7(8):e2346. doi: 10.1371/journal.pntd.0002346. Print 2013.

20.

Dengue dynamics and vaccine cost-effectiveness in Brazil.

Durham DP, Ndeffo Mbah ML, Medlock J, Luz PM, Meyers LA, Paltiel AD, Galvani AP.

Vaccine. 2013 Aug 20;31(37):3957-61. doi: 10.1016/j.vaccine.2013.06.036. Epub 2013 Jun 20.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk